The survival analysis results suggest that pyrvinium pamoate targets β-catenin and inhibits tumor growth, thereby increasing the survival of mice injected with NIH/3T3 clones overexpressing UBE3C-LRP5 fusion (Fig. 6d). Here, UBE3C is linked to neoplasm.